Wordt geladen...
Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury
Dapagliflozin, a new type of drug used to treat diabetes mellitus (DM), is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Although some studies showed that SGLT2 inhibition attenuated reactive oxygen generation in diabetic kidney the role of SGLT2 inhibition is unknown. We evaluated whether SLT...
Bewaard in:
| Gepubliceerd in: | PLoS One |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4938401/ https://ncbi.nlm.nih.gov/pubmed/27391020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0158810 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|